zoom_in Click to enlarge

James Black

▲ ▼

description James Black Overview

James Black was a Scottish pharmacologist renowned for his pioneering work in rational drug design. His research fundamentally changed how medications were developed, particularly with the creation of beta-blockers – widely used to treat cardiovascular conditions. He received the 1988 Nobel Prize recognizing his significant contributions to medicine and pharmacology. Black’s innovations are primarily relevant to medical professionals and researchers involved in pharmaceutical development and treatment strategies for heart disease and gastrointestinal disorders.

help James Black FAQ

Which two important drugs did James Black develop?

James Black developed propranolol, a beta-blocker that reduces the effects of adrenaline on the heart, and cimetidine, which suppresses gastric acid production. These discoveries helped establish receptor-based drug design as a practical approach to treating disease.

How does propranolol relate to James Black's research?

Propranolol blocks beta-adrenergic receptors, reducing adrenaline's effects on heart rate and contraction. Black developed it in the early 1960s, and it became an important treatment for cardiovascular conditions.

What is cimetidine, the drug associated with James Black?

Cimetidine is an H2-receptor antagonist that reduces the production of stomach acid and was used to treat ulcers. Black developed it in the early 1970s after applying receptor pharmacology to gastric secretion.

Why did James Black win the 1988 Nobel Prize?

Black shared the 1988 Nobel Prize in Physiology or Medicine with Gertrude Elion and George Hitchings for discoveries of important principles for drug treatment. His contribution was the use of receptor theory to design drugs such as propranolol and cimetidine.